[1]
“Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and the Emerging Role of Resmetirom: A Comprehensive Review”, JIMC, vol. 8, no. 1, Dec. 2025, Accessed: Feb. 03, 2026. [Online]. Available: https://jimc.org.pk/index.php/jimc/article/view/75